KRAS and pancreatic intraductal papillary-mucinous neoplasm: Most studies showed the very high frequency of KRAS and GNAS mutations in IPMN, associated with mutations of TP53 in a smaller subset of more aggressive lesions, and by some recurrent aneuploidies and focal deletions of tumor suppressor genes [19–23].